Åsa Rosenquist

Åsa Rosenquist has worked in a variety of roles in the pharmaceutical industry since 1997. Åsa began their career as a Post Doc at UC Berkeley, followed by a Research Scientist position at AstraZeneca in 1999. Åsa then held three positions at Linköping University from 1999-2017, including Associate Professor (20%), Assistant Professor (20%), and Assistant Professor (50%). In 2017, they began their role as Head of Unit for Diagnostic Preparedness of Notifiable and High Consequence Pathogens at Folkhälsomyndigheten. Åsa also took on the role of Project and Portfolio Manager, Team Leader Target Biology, and Project Leader at Karolinska Institutet in 2017. In 2018, they became Director Innovation at XSPRAY PHARMA AB (PUBL). Her current role is VP R&D-Operations, Laboratory Director at iCellate Medical AB, which they have held since 2019.

Åsa Rosenquist obtained a PhD in Organic Chemistry from Linköping University between 1986 and 1997.